Home > Products > CD19 & CD22
> Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG(L)-scFv)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-039)
Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD19 antibody are fused to the C terminus of an anti-CD22 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG(L)-scFv) (IGLFV-039). Click the button below to contact us or submit your feedback about this product.